People & Business :: Companies
BASF increases offer price for acquisition of Pronova BioPharma
11:43 AM MST | January 15, 2013 | Sotirios Frantzanas
BASF says it has increased its cash-offer price for the proposed acquisition of all of the issued and outstanding shares of Pronova BioPharma (Lysaker, Norway), to 13.50 Norwegian kroner/share ($2.43). The previous offer price was NK12.50/share. BASF has extended the offer period, in December, until 18 January 2013, and said that was the maximum extension of the offer period. "The increased offer corresponds to a premium of 34% above the volume-weighted average share price for Pronova's shares in the 6 months prior to announcement of the public...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee